Distribution of malignant lymphoma in Japan: Analysis of 2260 cases, 2001-2006

Pathology International

Volumn 58, Issue 3, 2008, Pages 174-182

  Aoki, Ryosuke ^a   Karube, Kennosuke ^a,c   Sugita, Yasuo ^a   Nomura, Yuko ^b   Shimizu, Kay ^a   Kimura, Yoshizo ^a   Hashikawa, Keiko ^a   Suefuji, Nobuko ^a   Kikuchi, Masahiro ^b   Ohshima, Koichi ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

Distribution; Japan; Malignant lymphoma

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CANCER EPIDEMIOLOGY; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; FOLLICULAR LYMPHOMA; GEOGRAPHY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; JAPAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; NATURAL KILLER T CELL; PATHOLOGY; PRIORITY JOURNAL; SEX RATIO; T CELL LEUKEMIA; T CELL LYMPHOMA; TUMOR BIOPSY;

HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; JAPAN; LEUKEMIA-LYMPHOMA, ADULT T-CELL; LYMPHOMA; LYMPHOMA, FOLLICULAR; LYMPHOMA, LARGE B-CELL, DIFFUSE; TUMOR MARKERS, BIOLOGICAL;

EID: 38849130620     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2007.02207.x     Document Type: Article

References (30)

1. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS. Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood 2006 107:265 76.
2. Muller AM, Ihorst G, Mertelsmann R, Engelhardt M. Epidemiology of non-Hodgkin's lymphoma (NHL): Trends, geographic distribution, and etiology. Ann Hematol 2005 84:1 12.
3. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994 84:1361 92.
4. Non-Hodgkin's Lymphoma Pathologic Classification Project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: Summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. Cancer 1982 49:2112 35.
5. Jaffe ES, Harris NL, Stein H, Vardiman JM, eds. Pathology and Genetics of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France:IARC Press, 2001.
6. Lymphoma Study Group of Japanese Pathologists. The World Health Organization classification of malignant lymphomas in Japan: Incidence of recently recognized entities. Pathol Int 2000 50:696 702.
7. Hammer MF, Horai S. Y chromosomal DNA variation and the peopling of Japan. Am J Hum Genet 1995 56:951 62.
8. Hammer MF, Karafet TM, Park H et al. Dual origins of the Japanese: Common ground for hunter-gatherer and farmer Y chromosomes. J Hum Genet 2006 51:47 58.
9. Ohshima K, Takeo H, Kikuchi M et al. Heterogeneity of Epstein-Barr virus infection in angioimmunoblastic lymphadenopathy type T-cell lymphoma. Histopathology 1994 25:569 79.
10. Ohshima K, Kikuchi M, Masuda Y et al. Defective provirus form of human T-cell leukemia virus type I in adult T-cell leukemia/lymphoma: Clinicopathological features. Cancer Res 1991 51:4639 42.
11. Guo Y, Karube K, Kawano R et al. Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances. Leukemia 2005 19:1058 63.
12. Ohshima KS, Suzumiya J, Kawasaki C, Kanda M, Kikuchi M. Cytoplasmic cytokines in lymphoproliferative disorders: Multiple cytokine production in angioimmunoblastic lymphadenopathy with dysproteinemia. Leuk Lymphoma 2000 38:541 5.
13. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: Distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol 1998 9:717 20.
14. Ko YH, Kim CW, Park CS et al. REAL classification of malignant lymphomas in the Republic of Korea: Incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer 1998 83:806 12.
15. Intragumtornchai T, Wannakrairoj P, Chaimongkol B et al. Non-Hodgkin's lymphomas in Thailand. A retrospective pathologic and clinical analysis of 1391 cases. Cancer 1996 78:1813 19.
16. Miyazato H, Nakatsuka S, Miyanaga I et al. Follicular lymphoma in Osaka, Japan: Histological features and chronological change. Int J Hematol 2002 76:333 7.
17. Yanagihara ET, Blaisdell RK, Hayashi T, Lukes RJ. Malignant lymphoma in Hawaii-Japanese: A retrospective morphologic survey. Hematol Oncol 1989 7:219 32.
18. Suchi T, Tajima K, Nanba K et al. Some problems on the histopathological diagnosis of non-Hodgkin's malignant lymphoma: a proposal of a new type. Acta Pathol Jpn 1979 29:755 76.
19. Kadin ME, Berard CW, Nanba K, Wakasa H. Lymphoproliferative diseases in Japan and Western countries: Proceedings of the United States-Japan Seminar, September 6 and 7, 1982, in Seattle, Washington. Hum Pathol 1983 14:745 72.
20. Jaffe ES. Hematopathology: Integration of morphologic features and biologic markers for diagnosis. Mod Pathol 1999 12:109 15.
21. Ohshima K, Suzumiya J, Sato K et al. Nodal T-cell lymphoma in an HTLV-I-endemic area: Proviral HTLV-I DNA, histological classification and clinical evaluation. Br J Haematol 1998 101:703 11.
22. Tajima K. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: Estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. Int J Cancer 1990 45:237 43.
23. Sato E, Tokunaga M, Hasui K, Kitajima S, Nomoto M. Pathoepidemiological features of adult T-cell lymphoma/leukemia in an endemic area: Kagoshima, Japan. Cancer Detect Prev 1990 14:423 9.
24. Hasui K. Paraffin-immunohistochemical analysis of 226 non-Hodgkin's malignant lymphomas in the endemic area of human T-cell leukemia virus type 1. Acta Pathol Jpn 1991 41:350 62.
25. Jaffe ES, Chan JK, Su IJ et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol 1996 20:103 11.
26. Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 1997 89:3909 18.
27. Lardelli P, Bookman MA, Sundeen J, Longo DL, Jaffe ES. Lymphocytic lymphoma of intermediate differentiation. Morphologic and immunophenotypic spectrum and clinical correlations. Am J Surg Pathol 1990 14:752 63.
28. Armitage JO, Weisenburger DD. New approach to classifying non-Hodgkin's lymphomas: Clinical features of the major histologic subtypes. Non-Hodgkin's Lymphoma Classification Project. J Clin Oncol 1998 16:2780 95.
29. Bosch F, Lopez-Guillermo A, Campo E et al. Mantle cell lymphoma: Presenting features, response to therapy, and prognostic factors. Cancer 1998 82:567 75.
30. Kant JA, Hubbard SM, Longo DL, Simon RM, DeVita VT Jr, Jaffe ES. The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin's disease. J Clin Oncol 1986 4:284 94.